Responses

Download PDFPDF
Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Abnormal liver enzymes and diabetes risk: potential contribution of chronic viral hepatitis was underplayed
    Sir,

    Xu et al report an association between deranged liver enzymes e.g. alanine transaminase (ALT) in Chinese people residing in Southern China and the incidence of diabetes [1].

    The authors examined multiple potential confounding factors which could influence liver enzymes e.g. alcohol consumption & adiposity. However, although the authors briefly mentioned chronic viral hepatitis infections i.e. chronic hepatitis B...

    Show More
    Conflict of Interest:
    None declared.